Aparna Parikh shared on X:
“More on adjuvant timing.
Will be interesting to see surveillance ctDNA studies read out. Also, importance of ctDNA turn around time thinking of use cases. Improved plasma-only approaches and/or workflows for tumor informed immediately post op.”
Source: Aparna Parikh/X
Authors: Mikail Gögenur, Andreas Weinberger Rosen, Timothy Iveson, et al.